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Abstract 
Atherosclerosis is one of the leading causes of death. Preventing atherosclerosis starts 
with controlling the build-up of plaque in the arteries. Due to the current obesity epidemic, 
preventing atherosclerosis through the diet is increasingly important. The types of dietary fats 
consumed may lead to changes in plaque content and reduce risk for plaques to form lesions that 
stick to the arterial wall. Dietary sesame oil reduces arteriosclerotic plaque formation in mice 
prone to developing atherosclerosis. Because the liver is the major site for cholesterol 
metabolism and therefore, contributes to atherosclerotic disease in this way, we hypothesize a 
sesame oil diet would reduce inflammation in the livers of mice.  Using the LDLr -/- mouse, 
which is prone to atherosclerosis, we measured mRNA for several genes coding for 
inflammation and infiltration of macrophages (e.g., IL-6, TNFα, TNFα receptor, and F4/80) in 
the liver. In contrast to our hypothesis, markers of inflammation appear to be elevated in mice 
fed sesame oil. We suspect the elevation of the inflammation markers measured was an indirect 
effect of dietary sesame oil inducing lipid accumulation in the liver. In order to test the causative 
effect of sesame oil on lipid accumulation and inflammation, we will quantify the fat content 
(triglyceride, diglyceride and monoglyceride) in the liver of mice fed the sesame oil. Once we 
have a better assessment of dietary induced changes of the liver lipid composition, we will know 
more about why livers are exhibiting enhanced markers of inflammation in mice fed sesame oil 
diets.  
Introduction 
Atherosclerosis is a major contributor to heart disease, which has been the leading cause 
of death in the U.S. in recent years (1). It is believed the development of arteriosclerotic plaque is 
caused by inflammation in the arteries that starts out as a fatty streak on the wall of the artery 
eventually progressing into a plaque.  This plaque build-up becomes dangerous when there is 
possibility of it rupturing. What determines whether or not a plaque will be prone to rupture is 
dependent on its makeup (2). Increased levels of cholesterol (3) and saturated fatty acids 
combined with macrophages and other inflammatory markers may contribute to this potentially 
life-threatening condition by creating an unstable plaque that may break through the fibrous cap 
that has formed (4). Vulnerable plaques that rupture through their fibrous cap can be severe 
enough to cause a blood clot resulting in a heart attack or stroke if the plaque is large enough (i.e. 
containing many lipids, cholesterol, macrophages, and other debris) (5). Many studies have 
tested this causal relationship between inflammation and atherosclerotic plaque development in 
the hopes of finding a way to prevent an inflammatory response. Recently it has been found the 
amount of fat being consumed is proving to be less important than the types of fats being 
consumed. Unlike saturated fatty acids, unsaturated fatty acids have shown to lower low-density 
lipoprotein (LDL)-cholesterol levels while increasing HDL-cholesterol levels (6, 7). This anti-
atherogenic effect of monounsaturated fatty acids (MUFAs) and polyunsaturated fatty acids 
(PUFAs) by increasing HDL-cholesterol levels is promising for unsaturated fatty acids in normal 
subjects. However, MUFAs, when compared to PUFAs have shown to be pro-atherogenic in 
LDL receptor knockout mice (8). These LDLr -/- mice are prone to developing atherosclerosis 
due to their impaired lipid transport abilities (9). PUFAs have shown to reduce atherosclerosis 
development in LDLr -/- mice, which has been the focus of some anti-atherogenic studies 
recently (10). Sesame oil, which is known to have a 1:1 MUFA:PUFA ratio was chosen in this 
study due to its high PUFA levels (11). Sesame oil has also been shown to reduce the formation 
of the arteriosclerotic lesion in LDLr -/- mice (12). These points taken together show a promising 
sign for the anti-atherogenic signs of the PUFAs in sesame oil. There has also been preliminary 
data for a clinical study involving sesame oil that has shown sesame oil reduces pro-
inflammatory markers as well as increasing anti-inflammatory markers in adipose tissue (data 
not published). With this evidence we hypothesized that a sesame oil diet would reduce 
inflammation in the livers of mice. 
Methods 
Mice and Diets Male LDLr -/- mice (n=12) were divided into two groups of six and were 
fed a control diet or a sesame diet. The control group was given the Teklad 17% AMF 
(anhydrous milkfat) diet TD.04287 with .2% cholesterol, Harlan Laboratories Inc, Madison, 
Wisconsin USA. The sesame group was given the Teklad 17% sesame oil diet TD.04288 with 
.2% cholesterol, Harlan Laboratories Inc, Madison, Wisconsin USA. The remaining content of 
the diets was identical. The mice were fed the experimental diets for three months; then were 
sacrificed and livers collected and preserved for future analysis.  
mRNA Analysis of Target Genes in Liver qRT-PCR was used to measure the mRNA 
levels of four pro-inflammatory gene markers: IL-6, TNFα, TNFαR, and F4/80. 50mg of liver 
was cut and homogenized for 15 seconds in 1.5ml of qiazol. Samples incubated for 5 min at 
room temperature (RT) and then 300ul of CHCl3 was added. Samples were incubated again for 3 
minutes at RT and spun at 12000g for 15 minutes at 4˚C in our microcentrifuge. The top phase 
created was removed and 750 ul of isopropanol was added. The tube was then gently inverted 3 
times and incubated at RT for 10 minutes. After 10 minutes the samples were spun at 12000g for 
10 min at 4˚C where a small white pellet of RNA was left. The pellet was dried and then added 
to 1.5 ml of 75% ethanol. The mixture was vortexed quickly and then spun at 7500g for 5 
minutes at 4˚C. The ethanol was removed and 40 ul of RNase-free DI H2O was added to break 
up the pellet. The mixture was vortexed and then incubated for 10 minutes at 55˚C on a hotplate. 
After the incubation the sample was stored at -80˚C. After the RNA extraction was completed 
the reverse transcription of RNA to cDNA was next. The RT Master Mix Buffer was made, 
which included: 24 ul of 10x RT Buffer, 9.6 ul of 25x dNTPs, 24 ul of 10x Random Primers, 12 
ul of Multiscribe RTase, and 50.4 ul of RNase-free DI H2O. 10 ul of RT Master Mix Buffer and 
10 ul of sample/RNase-free H2O were added to each PCR tube. The PCR tubes were mixed, 
vortexed, and then inverted. The PCR tubes were next put in the thermal cycler for 10 minutes at 
25˚C, 120 minutes at 37˚C, 5 minutes at 85˚C, then 60 minutes at 4˚C. The newly created cDNA 
was then stored long-term at -25˚C. The TaqMan Universal PCR Master Mix reagent with 
primers was made next, which included: 300 ul of TaqMan Universal PCR Master Mix, 30 ul of 
RNase-free DI H2O, and 30 ul of TaqMan gene expression target gene, or 30 ul of TaqMan 
endogenous control. The target gene and endogenous control were separated so the plates could 
be run singleplex. ddCt analysis was then used to compare the cycle thresholds of each gene to 
housekeeping mRNA for GAPDH. 
Lipid Concentration of Liver The total fat content in the liver was calculated to 
compare between the two diet groups. The livers were cut and put into 6 ml of CHCl3. Before the 
samples or CHCl3 were added the test tubes were weighed. 1 ml of 0.88% KCl was added and 
spun at 1000g for 15 minutes at 4˚C. The top 0.88% KCl layer was removed completely and the 
samples were spun at 1000g for 15 minutes at 4˚C. The remaining 0.88% KCl was removed 
again and the remaining CHCl3 was dried under the nitrogen dryer. After the CHCl3 was dried 
the test tubes were weighed and the difference between the two test tube weights was calculated. 
The fat content in the liver was extracted and methylated for fatty acid analysis by gas 
chromatography (GC). The livers were cut and put in 4 ml CHCl3. 1 ml of 0.88% KCl was added 
and spun at 1000g for 15 minutes at 4˚C. The 0.88% KCL layer was removed, 1 ml of CHCl3 
was added, and then respun at 1000g for 15 minutes at 4˚C. The remaining 0.88% KCl was 
removed and the remaining CHCl3 was dried under the nitrogen dryer. 300 ul of hexane was then 
added to the tubes, vortexed, and transferred to the GC vials and stored at -25˚C. The GC allows 
for the quantification of various fatty acids present in each sample. The GC quantifies the fatty 
acids by plotting retention time versus concentration and calculating the percent area that is 
found under the curve. 
 Statistical Evaluation of Data delta delta Cycle threshold (ddCt) analysis was used to 
compare the amplification between the target genes and endogenous control. The delta cycle 
threshold (dCt) for the control group was calculated by subtracting the average Ct for the 
endogenous control from the average Ct for the target gene. The average Ct values for the target 
genes and endogenous control were found next for each mouse whereafter the value for the 
endogenous control was subtracted from the target gene to calculate the dCt value. The ddCt 
value was calculated next by subtracting the dCt value found for the entire control group from 
the dCt value found from each individual mouse. In order to normalize the target gene data to the 
endogenous control the ddCt values were then taken and put into the equation 2(-ddCt) where the 
values were then averaged for each diet group and their standard deviations calculated. The total 
lipid content was calculated by subtracting the weight of the empty test tube from the weight of 
the test tube containing the fat whereafter the average for each diet group was found and the 
standard deviations calculated. A t test was done to calculate the statistical significance for each 
value compared to a control value. The p values were considered significant if p<0.05.  
Results 
 The level of F4/80 mRNA in the sesame group was significantly decreased in comparison 
to the control group (Figure 1). The level of IL-6 mRNA was not significantly different between 
the sesame group and control group (Figure 2). The mRNA level of TNFα in the sesame group 
was significantly decreased in comparison to the control group (Figure 3). The level of TNFαR 
was not significantly different between the sesame group and the control group (Figure 4). The 
quantity of lipid accumulation in the livers of the control group was significantly higher than 
amounts of lipid in mice fed control diet. The fatty acid composition of the diet and livers of the 
mice fed diets are shown in Table 1 (Table 1A, Sesame diet; Table 1B, Control Diet).  
Discussion 
 Our overall hypothesis was that sesame oil would decrease inflammatory markers in the 
liver. Our finding that the sesame oil diet significantly decreased mRNA levels of F4/80 and 
TNFα compared to the control fed mice supported out hypothesis. These two transcripts are 
normally associated with a pro-inflammatory response in the liver, but their decrease in 
expression of the mice fed the sesame oil diet shows support for our hypothesis of decreasing 
pro-inflammatory markers in sesame oil fed mice. Sesame oil was shown to decrease total lipids 
and MUFAs in the liver while increasing PUFAs as well. It is believed PUFAs have the ability to 
reduce atherosclerosis development, and the high PUFA levels in sesame oil may be related to 
the significant decrease in mRNA expression of F4/80 and TNFα. MUFAs have also been shown 
to have pro-atherogenic qualities (8), which could help explain the decrease in the pro-
inflammatory F4/80 and TNFα in the sesame oil mice compared to the control group mice. The 
decrease in the pro-inflammatory gene markers coupled with a decrease in total lipid content in 
the sesame oil group shows that sesame oil is reducing two major factors for arteriosclerotic 
plaque formation. The reduction in the pro-inflammatory markers could have been due to an 
increase in PUFAs, a decrease in MUFAs, or something else we did not measure, but the signs 
are promising for sesame oil and specifically the PUFAs in the sesame oil for possibly 
decreasing an inflammatory response leading to atherosclerotic plaque formation. 
Limitations and Future Directions 
 One limitation is the number of mice used, which were 6 mice per group in this study. 
Many studies use 15 or more mice per group due to the variability of responses to diet-induced 
changes in inflammation and responses to the test oil (sesame). A second limitation is that we did 
not handle the mice; instead, the mice were fed, sacrificed, and their livers by others were sent to 
us from another lab. Actually seeing the process the entire way from receiving the mice and 
feeding them, all the way to necropsy would have been advantageous. 
 Future directions of the study should address other lipid responses in the liver due to 
supplementing sesame oil. These may include cholesterol metabolism, which was the same in 
these diets and not measured, but may be able to predict the protective effect of sesame oil for 
atherosclerosis. 
 
 Figure 1: Fold change in expression of F4/80 mRNA levels in the control and sesame oil groups. 
The sesame oil fed mice had significantly (p<0.05) decreased F4/80 mRNA levels compared to 
the control group. 
Figure 2: Fold change in expression of IL-6 mRNA levels in the control and sesame oil groups. 
There was no statistical significance between the two groups. 
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 Figure 3: Fold change in expression of TNFα mRNA levels in the control group and sesame oil 
groups. The sesame oil fed mice had significantly (p<0.05) decreased TNFα mRNA levels 
compared to the control group. 
Figure 4: Fold change expression of TNFαR mRNA levels in the control and sesame oil groups. 
There was no statistical significance between the two groups.  
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Figure 5: Total fat content of sesame oil and control fed mice. The sesame oil fed mice had 
significantly (p<0.05) lower amounts of total fat. 
 
Table 1: Fatty acid composition of diet and liver for mice fed the sesame oil diet. 
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 Table 2: Fatty acid composition of diet and liver for mice fed the control diet.  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